Riverwater Partners LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1882572 Milwaukee, WI

Position in TMO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$419,136

-$743,332 QoQ

Shares Held

836

-64.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,843

of 2,602 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Riverwater Partners LLC holds $5,866,782 across 4 Diagnostics & Research names. TMO ranks #3 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DGX	Quest Diagnostics Inc	21,609	$4,580,027
2	DHR	Danaher Corp /De/	2,564	$488,390
3	TMO	Thermo Fisher Scientific Inc. This page	836	$419,136
4	A	Agilent Technologies, Inc.	2,855	$379,229

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$419,136	836	-64.7%	Shares	Sole	2026-08-14
2026-03-31	$1,162,468	2,365	+2.5%	Shares	Sole	2026-05-08
2025-12-31	$1,337,370	2,308	+4.8%	Shares	Sole	2026-02-12
2025-09-30	$1,068,014	2,202	+14.3%	Shares	Sole	2025-10-31
2025-06-30	$781,321	1,927	+16.1%	Shares	Sole	2025-08-01
2025-03-31	$826,016	1,660	-8.4%	Shares	Sole	2025-04-21
2024-12-31	$942,656	1,812	+5.3%	Shares	Sole	2025-02-13
2024-09-30	$1,064,558	1,721	-1.5%	Shares	Sole	2024-10-22
2024-06-30	$966,644	1,748	-1.6%	Shares	Sole	2024-07-19
2024-03-31	$1,032,228	1,776	-0.9%	Shares	Sole	2024-04-19
2023-12-31	$951,706	1,793	+0.8%	Shares	Sole	2024-01-05
2023-09-30	$900,476	1,779	-0.7%	Shares	Sole	2023-10-18
2023-06-30	$934,454	1,791	-0.7%	Shares	Sole	2023-07-18
2023-03-31	$1,039,771	1,804	-23.4%	Shares	Sole	2023-04-12
2022-12-31	$1,296,874	2,355	+4.9%	Shares	Sole	2023-01-12
2022-09-30	$1,138,134	2,244	+7.5%	Shares	Sole	2022-11-08
2022-06-30	$1,133,825	2,087	+108.3%	Shares	Sole	2022-08-05
2022-03-31	$591,831	1,002	-53.6%	Shares	Sole	2022-05-02
2021-12-31	$1,439,903	2,158	—	Shares	Sole	2022-01-31
No filing history on record for this holder in this stock.